October 30, 2014
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations USA TODAY Could a robot do your […]
Tags: A.L.S., ABC News, Ahwatukee Foothills News, Albert Lea Tribune, alzheimer's disease, Alzheimer's Disease and eye test, Angela Lunde, Angie’s Artisan Treat, Anna Stoehr, Argus Leader, Arizona Leadership Council, Arizona Republic
March 8, 2013
Hugo Chavez Death Highlights Heart Risk After Cancer
A heart attack ended up killing Venezuelan president and longtime cancer sufferer Hugo Chavez, a source close to Chavez revealed. And cancer experts say that’s not unusual…Anti-cancer drugs such as anthracyclines, a mainstay of breast cancer chemo, as well as newer medications such as the drug Herceptin may cause heart damage by weakening the heart muscle, Dr. Timothy […]
Tags: ABC News, anthracyclines, anti-cancer drugs, Dr. Timothy Moynihan, heart attack, heart damage, Herceptin, Hugo Chavez
July 26, 2012
The Latest Word on Breast Cancer
This year, more than 22,000 Canadian women were diagnosed with breast cancer. That’s a pretty frightening statistic, but advances in diagnostic techniques as well as in treatments are improving our odds of beating the disease… New Treatment Options: Tykerb – About 20% of breast cancer cases are HER-2, an aggressive form of cancer. A drug […]
Tags: diagnostic techniques, Dr. Edith Perez, Herceptin, Reader's Digest Canada
January 16, 2012
HER2 proteins do not predict breast cancer patient’s outcome after Herceptin treatment
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient’s outcome after treatment for HER2-Positive Breast Cancer with Herceptin, say Mayo Clinic researchers. HER2-positive breast cancer gets its name from a protein called human epidermal growth factor receptor 2 that […]
Tags: Edith Perez, Herceptin, M.D.
December 18, 2009
Use Herceptin and chemo together, says US researcher
The results of the only clinical trial so far to look at the relative impact of administering Roche’s Herceptin (trastuzumab) at the same time as, or following, chemotherapy are a rallying call for doctors to use the breast cancer drug concurrently, says the lead researcher for the US study. The N9831 trial, presented at […]
December 14, 2009
Herceptin therapy should start during chemotherapy, study says
Women with a type of breast cancer referred to as HER-2 positive are typically prescribed the medication Herceptin to lower the risk of cancer recurrence. A study published today makes clear that Herceptin therapy should begin at the same time as chemotherapy, not after chemotherapy is concluded. In about a quarter of women with […]
Tags: Chemotherapy, HER-2, Herceptin